| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Gline Matthew is a CEO at Roivant Sciences Ltd.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $528.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 8,509 | $3.84 | $32,674.56 | -0.6% | +2.7% | +115.8% | |
| Mar 30, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 33,686 | $4.84 | $163,040.24 | -2.3% | -0.8% | +54.2% | |
| Mar 25, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 35,386 | $5.06 | $179,053.16 | -2.3% | -6.4% | +39.0% | |
| Mar 18, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 82,006 | $5.13 | $420,690.78 | -5.2% | -26.4% | +67.6% | |
| Mar 7, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 92,324 | $5.52 | $509,628.48 | -5.5% | -26.2% | +51.9% |